AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Phase 1 Completed
50 enrolled
GEN602
Phase 1 Unknown
127 enrolled
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Study of Perifosine + Capecitabine for Colon Cancer Patients
Phase 1 Completed
10 enrolled
Capecitabine
Phase 1 Unknown
45 enrolled
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase 1 Completed
51 enrolled
Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer
Phase 1 Completed
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Phase 1 Completed
30 enrolled
Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors
Phase 1 Completed
40 enrolled
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1 Terminated
16 enrolled
GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
Phase 1 Completed
20 enrolled
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
Phase 1 Completed
13 enrolled
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer
Phase 1 Terminated
12 enrolled